The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta 08:30 – 08:45 Introductions and Overview of IHE Mr. Dan PalfreyDownload Presentation 08:45 – 09:30 Case Study One Mr. Dan PalfreyDownload Presentation 09:30 – 10:15 Innovation Adoption in Alberta and Canada Dr. Christopher McCabeDownload Presentation 10:15 – 10:30 Break 10:30 – 11:30 Principles of Health Economics…
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business…
On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business planning, and satisfy requirements of purchasers of technology. Participants…
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
This report provides a summary of a real-world evidence (RWE) design sprint workshop that took place on October 21, 2018 in Toronto, Ontario. The workshop was developed and delivered as a joint partnership between the Canadian Agency for Drugs and Technologies in Health (CADTH); Canadian Association for Population Therapeutics (CAPT), Health Canada, and the Institute of Health…
| Dat Tran, Robert Welsh, Arto Ohinmaa, Thanh Nguyen, Padma Kaul
Little is known about the resource use and cost burden of acute myocardial infarction (AMI) beyond the index event. We examined resource use and care costs during the first and each subsequent year, among patients with incident AMI.
This environmental scan describes existing initiatives that aim to accelerate the diagnostic phase of cancer care in Alberta, Canada, and internationally. Specifically, it describes their development and implementation, structure and functioning, intended outcomes and effectiveness, costs and cost savings, and enablers and barriers.
Summary Report Defining decision-grade real-world evidence and its role in the Canadian context: A design sprint – Summary report of a workshopDownload Summary Report (English) Définir les données probantes du monde réel utiles à la prise de décisions et leur rôle en contexte canadien: Un sprint de conception Rapport sommaire d’un atelier Téléchargez le rapport sommaire d’un atelier…
21 October 2018 Toronto, Ontario On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the…
PDF of a PowerPoint presentation by Dr. Kelvin Chan MD FRCPC MSc (Clin Epi) MSc (Biostats) PhD, Sunnybrook Odette Cancer Centre.
IHE/CAPT Real World Evidence Workshop
PDF of a PowerPoint presentation by Dr. Tammy Clifford, Chief Scientist and Vice-President, Evidence Standards, and Dr. Trevor Richter, Director, Common Drug Review and Optimal Use at CADTH.
IHE/CAPT Real World Evidence Workshop
On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the 2018 CAPT conference in Toronto,…
24 September 2018 Calgary, Alberta On September 24th, 2018 the Institute Health Economics (IHE) presented a roundtable at the BIO Alberta AGM and Conference. This Roundtable provided an overview of the IHE's education series for Alberta SMEs and ecosystem partners, and enabled participants to help define the content of the series so it would be most valuable to them. Beginning…
Health Technology Innovation Platform (HTIP) events are designed to support the HTIP initiative, by collaborating with and providing support for small- and medium-sized enterprises (SMEs) as well as multi-national enterprises (MNEs) in the life sciences. These events support the mission of the HTIP to enhance decision-making efficiency and improve value for money for purchasers…
14 September 2018 Edmonton, Alberta The Institute of Health Economics and The Network of Alberta Health Economists were pleased to present "Reflections on Balancing Academic and Policy Work," a mentorship and networking event for early career health economists (7 years or less from completion of PhD studies), with renown Health Economist, Dr. Karl Claxton, Professor of Economics,…
In the development of early stage life sciences technology, it's imperative to understand whether healthcare organizations are likely to purchase your innovation, and consequently provide a return on investment. Healthcare organizations make purchase decisions based upon clinical AND economic (value for money) considerations. Our early stage technology assessment service can help…
Speaker Biographies Keynote Speaker Dr. Catherine CalderwoodChief Medical Officer, Scotland Catherine Calderwood has been the Chief Medical Officer for Scotland since 2015. Catherine qualified from Cambridge and Glasgow Universities and continues to work as an obstetrician at a regular antenatal clinic at the Royal Infirmary of Edinburgh. She is responsible for the Health Promoting…
19 September 2018Edmonton, Alberta Welcome and Greetings WelcomeDr. Lorne TyrrellBoard Chair, IHE Greetings from the ProvinceMr. Justin RiemerAssistant Deputy Minister, Innovation and Strategic Operations Division, Alberta Healthhttps://vimeo.com/album/5450281/video/292002619 Keynote Presentations Realistic Medicine – Lessons from ScotlandDr. Catherine CalderwoodChief Medical Officer,…
19 September 2018Edmonton, Alberta Realistic Medicine - Trailer Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 18th IHE Innovation Forum Keynote Speaker is Dr. Catherine Calderwood, Chief Medical Officer for the Scottish Government.…
Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Institute of Health Economics – Corporate Reports The Institute of Health Economics (IHE) is a not-for-profit organization funded through grants and commissioned work from public and private sector partners. The IHE is committed to transparency and accountability in the work we conduct. Key corporate reports which are completed and in development are outlined below. Strategic Plan:…
4 – 6 November 2014 Edmonton, Alberta The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 – 6, 2014. Download Consensus Statement | Télécharger la déclaration de consensus The…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Past Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Events hosted or co-hosted by the IHE include the well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum series, Roundtables,…
The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.
| S.P. Bisch, T. Wells, L. Gramlich, P. Faris, X. Wang, Dat Tran, Thanh Nguyen, S. Glaze, P. Chu, P. Ghatage, J. Nation, V. Capstick, H. Steed, J. Sabourin, G. Nelson
The Institute of Health Economics has contributed to a study published in the Journal Gynecologic Oncology. The study described the effects of Enhanced Recovery After Surgery (ERAS) guideline implementation in gynecologic oncology on length of stay, patient outcomes, and economic impact in Alberta. The study compared pre-and post-guideline implementation outcomes at two centers…
This study originated from discussions on how to translate research findings into conclusions regarding safety and effectiveness in systematic reviews responding to requests from a provincial mechanism for introducing and diffusing publicly funded healthcare technologies. Its objective is to identify prominent and reliable evidence grading systems used in health technology assessment…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Health Technology Innovation Platform HTIP is a public-private partnership between Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), provincial drug plans (AB, BC, ON) and the innovative pharmaceutical industry including, Boehringer Ingelheim, GlaxoSmithKline, Roche Canada, Takeda Canada, and Novartis Pharmaceuticals Canada Inc. The HTIP goals include…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
This clinical practice guideline was produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project…
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project. The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
3 June 2018 Vancouver, British Columbia On June 3rd, as part of the 2018 Health Technology Assessment International (HTAi) Annual Conference in Vancouver, the Institute of Health Economics (IHE) led a panel presentation on facilitators, innovators, and innovations in chronic obstructive pulmonary disease (COPD) care in Canada. The panel, Facilitating Adoption of Innovative…
PDF of a PowerPoint Presentation by George Habib, President and CEO, Lung Association of Ontario.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of a PowerPoint presentation by Shelley Valaire, Senior Provincial Director, Respiratory Health Strategic Clinical Network (RHSCN), Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of PowerPoint presentation by Tatiana Makhinova, Assistant Professor, Faculty of Pharmacy and Pharmaceutical Services, University of Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal alcohol spectrum disorder (FASD) is a medical term used to describe a range of mental and physical disabilities caused by maternal alcohol consumption. The role of alcohol as a teratogen and its effects on the cellular growth of the embryo and the fetus were not determined on scientific grounds until the late 1960s. However, the link between alcohol use during…
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal Alcohol Spectrum Disorder (FASD) is a preventable disorder caused by maternal alcohol consumption and marked by a range of physical and mental disabilities. Although recognized by the scientific and medical community as a clinical disorder, no internationally standardized diagnostic tool yet exists for FASD. Methods and Results: This review seeks to analyse the…
| Charles Yan, Yufei Zheng, Michael D. Hill, Balraj Mann, Thomas Jeerakathil, Noreen Kamal, Shy Amlani, Anderson Chuck
Abstract: We present a conceptual approach to determine the optimal solution to delivering a health technology, consistent with the objective of maximizing patient outcomes subject to resources available to a publicly funded health system. The article addresses two key policy questions: 1) adding system values through appropriate planning of health services delivery and 2) considering…
This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
As the Federal Government contemplates introducing an element of value-based pricing to the pharmaceutical industry regulatory framework, this report provides an overview of key theoretical and empirical material, to support informed engagement by all stakeholders in this important debate.
Program
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum – Final ProgramDownload Final Program
Selected References
Dr. Holroyd's Selected References – Low Value Care / Cognitive BiasesDownload Selected References
Thursday, 22 February 2018Edmonton, Alberta 13:00 – 13:15 Welcome from the IHE Dr. Chris McCabeCEO, Institute of Health Economicshttps://vimeo.com/album/5021382/video/258736790 Greetings from the Province of Alberta Mr. Justin RiemerADM, Innovation & Strategic Operations, Alberta Healthhttps://vimeo.com/album/5021382/video/257997522 13:15 – 14:35 Where Does the…
Speaker Biograpies Keynote Speakers Dr. Brian O’Rourke Dr. Brian O’Rourke is the President and Chief Executive Officer of CADTH. He joined CADTH in January of 2009 following a distinguished career as a Pharmacist and Health Service Executive with the Canadian military. With over 30 years of experience in health care, Brian actively positions CADTH as the leading source…
22 February 2018 Edmonton, Alberta On February 22nd, 2018 the Institute Health Economics (IHE), the Canadian Agency for Drugs & Technologies in Health (CADTH), and Alberta Health presented a forum: Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making. The purpose of this event was to provide a platform for shared learning and to showcase CADTH and Alberta…
PDF of a PowerPoint presentation by Dr. Brian O’Rourke, CEO, Canadian Agency for Drugs and Technology in Health.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
PDF of a PowerPoint presentation by Dr. Sean Tunis, President, Health Technology Assessment International; Founder and CEO, Centre for Medical Technology Policy.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
| Rodger Craig, Carmen Moga, Bing Guo, Dagmara Chojecki
The Institute of Health Economics (IHE) was commissioned by the Canadian Cardiovascular Society to provide a rapid update of the literature, to compare the impacts of public reporting and external benchmarking on selected outcomes, and to evaluate and describe the applicability of this body of research to non- competitive health systems, emphasizing perspectives and considerations…
Objective: The aim of this study was to analyze the health care costs and savings associated with quality improvement (QI) interventions initiated and implemented utilizing the National Surgical Quality Improvement Program (NSQIP). Background: Five acute care facilities of Alberta Health Services (AHS) adopted NSQIP in 2015 for a pilot project. Methods: The cost-savings of NSQIP…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…
This report provides a summary of the proceedings from the IHE roundtable on diabetes care and management in Indigenous populations in Canada, held on November 1, 2017. The roundtable aimed to: discuss and share learnings and promising practices from successful community-led diabetes programs, highlighting approaches to effectively engage communities to co-develop prevention and…
| John Paul Ekwaru, Arto Ohinmaa, Sarah Loehr, Solmaz Setayeshgar, Thanh Nguyen, Paul J Veugelers
Objective: Public health decision makers not only consider health benefits but also economic implications when articulating and issuing lifestyle recommendations. Whereas various estimates exist for the economic burden of physical inactivity, excess body weight and smoking, estimates of the economic burden associated with our diet are rare. In the present study, we estimated the…
12 December 2016 Ottawa, Ontario On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. Download Summary Report Real-world evidence: What role can it play in real-world decision making? Summary Report The…
On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. The meeting brought together 11 representatives of key stakeholders: experts in evidence assessment, payers, and those generating RWE including academia…
This overview report provides a summary of the published information on the oxygen therapy issues studied in the past 10 years in the acute care settings. The report includes a summary of audit studies that aimed to address appropriate/inappropriate use of oxygen, and explores the safety and quality issues identified in the literature about oxygen prescription, administration,…
This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on October 6, 2016 in Edmonton. The intent of the forum was to inform Alberta biosimilar reimbursement policy by sharing international experiences in this area, and the perspectives of key stakeholders.
This rapid report provides a summary of current evidence on the application of gainsharing shared savings strategies in healthcare systems and the barriers and facilitators related to their implementation.
Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.
7 November 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Greetings from GovernmentMr. Martin Chamberlain, Senior Assistant Deputy Minister, Ministry Operations and Financial and Corporate Services, Alberta Health https://vimeo.com/channels/907291/191869994 Keynote presentations Assessing European Efforts…
7 November 2016Edmonton, Alberta Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 16th IHE Innovation Forum Keynote Speakers were Dr. Richard B. Saltman, Co-founder of the European Observatory on Health Systems…
Speaker Biographies Keynote Speakers Dr. Gregory P. Marchildon, PhD Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN) Dr. Marchildon is Ontario Research Chair in…
Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Gregory P. Marchildon, Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto; Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN). IHE Innovation Forum XVI – Controlling Health…
The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF), held a forum on April 25th, 2016 in Toronto, Ontario, entitled Optimizing access to care for patients with idiopathic pulmonary fibrosis: A multi-stakeholder national forum, to discuss the need for patient-led policy recommendations and a patient charter for idiopathic…
IHE Industry Partnerships The IHE has two key platforms that support partnership with industry and other stakeholders: the Health Technology Innovation Platform (HTIP), the Life Sciences SME Commercialization Platform. Health Technology Innovation Platform (HTIP) facilitates collaboration between a number of innovative pharmaceutical organizations…
| Thanh Nguyen, Anderson Chuck, Tracy Wasylak, Jeannette Lawrence, Peter Faris, Olle Ljungqvist, Gregg Nelson, Leah Gramlich
BACKGROUND: In February 2013, Alberta Health Services established an Enhanced Recovery After Surgery (ERAS) implementation program for adopting the ERAS Society colorectal guidelines into 6 sites (initial phase) that perform more than 75% of all colorectal surgeries in the province. We conducted an economic evaluation of this initiative to not only determine its cost-effectiveness,…
Thursday, 6 October 2016 Edmonton, Alberta 09:00 – 09:15 Introduction & WelcomeDr. Richard Fedorak 09:15 –10:15 The International Biosimilars Experience: Lessons for AlbertaMr. Murray AitkenSenior VP and Executive Director, IMS Institute for Healthcare InformaticsDownload Presentationhttps://vimeo.com/album/4209638/video/187499107 10:15 – 10:45 Table Reflection…
Biographies Dr. Richard N Fedorak, MD, FRCPC, FRCP (London), FRSC Dean of the Faculty of Medicine and Dentistry Professor of Medicine, Division of Gastroenterology University of Alberta, Edmonton, Alberta, Canada Dr. Richard N Fedorak is Dean of the Faculty of Medicine and Dentistry at the University of Alberta, Edmonton, Alberta, Canada. He is also Professor of Medicine in the…
6 October 2016 Edmonton, Alberta This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists to describe the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.…
Summary Report
Towards an Alberta approach for biosimilar reimbursement – Summary report of the IHE Biosimilars ForumDownload Summary Report
Program
IHE Biosimilars Forum – Final ProgramDownload Final Program
This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.
PDF of a PowerPoint presentation by Mr. Murray Aitken, Senior VP and Executive Director, IMS Institute for Healthcare Informatics.
6 Oct 2016 – IHE Biosimilars Forum
This white paper follows on from the 2016 IHE report, Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta. It provides a summary of main gaps in COPD care across Canada and, in the context of a broad economic framework, it surveys important examples of programs and policies designed to address these gaps.
| Arto Ohinmaa, Yufei Zheng, Thomas Jeerakathil, Scott Klarenbach, Unto Häkkinen, Thanh Nguyen, Dan Friesen, Jane Ruseski, Padma Kaul, Ruolz Ariste, Philip Jacobs
OBJECTIVES: This study aimed to evaluate the trends and regional variation of stroke hospital care in 30-day in-hospital mortality, hospital length of stay (LOS), and 1-year total hospitalization cost after implementation of the Alberta Provincial Stroke Strategy.
“The Canadian Idiopathic Pulmonary Fibrosis Patient Charter is a way to call upon policymakers, health care providers and private payers to recognize IPF as a rare, rapidly lethal, chronic disease and to join in the campaign for greater awareness of this illness. The ultimate goal is to improve the overall quality and standards of care and ensure equal access to a continuum…
Speaker Biographies Keynote Speakers Dr. Clemens Hong, MD, MPHMedical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services Dr. Hong is a primary care physician and the Medical Director of Community Health Improvement at the Los Angeles County Department of Health Services. His work centers on approaches…
22 June 2016Edmonton, Alberta High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 15th IHE Innovation Forum Keynote Speakers were Dr. Clemens Hong, Medical…
22 June 2016Edmonton, Alberta Welcome and Greetings Master of CeremoniesDr. Lorne Tyrrell, Chair, Institute of Health Economics Welcome RemarksMs. Heather Sweet, Member of Legislative Assembly, Edmonton-Manning; Dr. Alan Casson, Interim Assistant Deputy Minister of Health Standards, Quality and Performance and Senior Provincial Medical Advisor, Ministry of Health, Government of…
High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Mr. Truman Severson, Vice President, Innovation and Business Development, Covenant Health.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
PDF of a PowerPoint presentation by Dr. Clemens Hong, MD, MPH, Medical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Senior Medical Director, Provincial Primary Health Care, Alberta Health Services; Professor, Department of Medicine, University of Alberta.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
| Thanh Nguyen, Justin Ezekowitz, Dat Tran, Padma Kaul
BACKGROUND: Eplerenone has been demonstrated as being cost effective for the treatment of patients with systolic heart failure (HF) and mild symptoms in several jurisdictions; however, its cost effectiveness is unknown in the context of Alberta, Canada.
Objective: The objective of this paper is to estimate the additional mental health service costs incurred within the criminal justice system that are incurred because of people with mental illnesses who go through the system. Our focus is on costs in Alberta.
The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of theprovincial healthcare system, with a specific…
| Anderson Chuck, Thanh Nguyen, James Wesenberg, Rhada Chari, Robert Wilson, Selikke Janes-Kelley
Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…
This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide…
Summary Report Optimizing access to care for patients with idiopathic pulmonary fibrosis multi-stakeholder national forum – Summary report and recommendations for policy-makingDownload Summary Report Program Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis Multi-stakeholder National Forum – AgendaDownload Agenda Background Document Optimizing…
Monday, 25 April 2016 Toronto, Ontario Moderator: Chris Henshall Opening and Opening Remarks Don Husereau, IHEMehmood Alibhai, Boehringer Ingelheim (Canada) Ltd./LtéeDr. Chris Henshall, Chair, Health Technology Assessment International Policy Forumhttps://vimeo.com/album/3989243/video/169906196 Health care policy and idiopathic pulmonary fibrosis: Values of patients…
25 April 2016 Toronto, Ontario On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care. The forum…
PDF of a PowerPoint presentation by Dr. Martin Kolb, MD, PhD, Professor, Division of Respirology, Department of Medicine, McMaster University.
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
PDF of a PowerPoint presentation by Dr. Meena Kalluri, MD, Assistant Professor, Division of Pulmonary Medicine, University of Alberta.
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
PDF of a PowerPoint presentation by Mr. Robert Davidson, President, Canadian Pulmonary Fibrosis Foundation (CPFF).
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
In October 2015, we held the first Canadian consensus discussion that led to provisional recommendations regarding special considerations for policy-making and healthcare decisionmaking for interventions in patients with idiopathic pulmonary fibrosis (IPF). The meeting included 11 representatives of key stakeholders: patients, care providers, and policy researchers from across…
On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Foundation for Pulmonary Fibrosis (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care.
| Arianna Waye, Philip Jacobs, Maria Ospina, Michael Stickland, Irvin Mayers
This report provides the results of an economic surveillance analysis on the components of the Alberta healthcare system that are devoted to COPD prevention and treatment. It focuses on epidemiology (prevalence and incidence), service use, and cost indicators, and identifies gaps in the system that presumably add to the overall economic burden of COPD. PDF of the above image: IHE…
IHE brochure discussing a study on the use of technology to prevent FASD (fetal alcohol spectrum disorder).
FASD Ongoing Initiative
Prevention of Fetal Alcohol Spectrum Disorder by the Use of Technology Study
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…
Objectives: To estimate the life expectancy and specify the causes of death among people with fetal alcohol syndrome (FAS). Methods: Included were all patients recorded in Alberta provincial databases of inpatients, outpatients, or practitioner claims from 2003 to 2012. People with FAS were identified by ICD-9 code 760.71 and ICD-10 codes Q86.0 and P04.3, and were linked…
The IHE quality appraisal checklist for case series studies developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.
The IHE Quality Appraisal Checklist for Case Series Studies and guidance document developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This rapid report has been produced in response to a request from Alberta Health to provide an update on the new published research evidence on the efficacy/effectiveness, efficiency, and safety of hysteroscopic tubal sterilization (HTS) using the Essure® system for permanent…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the “Technological efficacy/effectiveness analysis” (T) section of the 2014 Alberta STE report, which was an evidence assessment of the clinical effectiveness and safety of endovenous ablation interventions for symptomatic varicose veins…
Career and Award Opportunities Work for us The IHE is proud to employ exceptional, experienced professionals. We welcome applications from all qualified persons for our posted career opportunities. The IHE is building capacity in research The IHE's focus on capacity building, by supporting health researchers, students, and economists with internships, fellowships, bursaries, and…
Abstract: Canada having a universal health insurance plan that provides hospital and physician benefits offers a natural experiment of whether continuity ofcare actually provides lower or higher utilization of services. The question we are evaluating is whether Canadians, who have a regular physician, use more health resources than those who do not have one? Using two statistical…
The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus…
The checklist has been used by researchers at IHE in HTA reports as well as by professionals in other organizations from various countries. Listed in reverse chronological order and updated on March 3rd, 2016. IHE Publications Institute of Health Economics. Hysteroscopic Tubal Sterilization. Edmonton AB: Institute of Health Economics. 2014. Download IHE Report Institute of Health…
The process by which the tool was developed, as well as a brief review of other published checklists and the results of a pilot test of the quality appraisal checklist are described in a 2012 IHE methodology paper. A preliminary validation study of the tool using factor analysis has also been conducted. Publications Listed in reverse chronological order. Guo B, Moga C, Harstall…
Policy Forum Summary Report
Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum – Summary Report Download Summary Report
Program
Policy Forum – Final ProgramDownload Final Program
Background Document
Alberta Fact SheetDownload Alberta Fact Sheet
Forum Summary
Policy Forum InfographicDownload Infographic
Monday, 8 February 2016 Edmonton, Alberta Please click the following link to watch video of afternoon sessions: Event Video 09:00 – 09:10 Welcome and Opening RemarksIHE and O'Brien Institute Leadershiphttps://vimeo.com/album/3800131/video/155338361 Morning Session: Understanding Our Shared Challenges 09:10 – 09:25 Setting the Stage: An Overview of Health Spending, Physician…
Biographies Dr. William Ghali, MD, MPH, FRCPCScientific Director, O'Brien Institute for Public Health Dr. Ghali is the Scientific Director of the O’Brien Institute for Public Health at the University of Calgary. He is also a Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary, and a practicing physician specialized in Internal Medicine.…
8 February 2016 Edmonton, Alberta The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum aimed to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which was attended by Health Minister Sarah Hoffman…
The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum aims to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which will also be attended by Health Minister Sarah Hoffman as lunch keynote speaker,…
PDF of a PowerPoint presentation by Dr. William Ghali, MD, MPH, FRCPC, Scientific Director, O'Brien Institute for Public Health.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. David Naylor, President Emeritus and Professor of Medicine, University of Toronto.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Peter Kaboli, Hospitalist and Chief of Medicine, Iowa City VA Healthcare System.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. David Price, Professor and Chair, Department of Family Medicine, McMaster University.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Sharon Straus, Professor, Department of Medicine, University of Toronto.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Carl Nohr, President, Alberta Medical Association, and Mr. Mike Gormley, Executive Director, Alberta Medical Association.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
2018 | 2017 |2016 | 2015 | 2014 | 2013 The Institute of Health Economics joined with Alberta Innovates (formerly known as Alberta Innovates-Health Solutions) in 2013 to create a new forum to bring stakeholders together to discuss health policy. The AI/IHE Health Policy Speaker Series features perspectives from leaders in the health system across the spectrum of health evidence,…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #17. The present report has been prepared as a follow up to the previous assessment because of continued interest in the technology by the health ministry and others. It considers studies that have been reported in the literature since completion of the earlier assessment (1997-1999) and focuses on the efficacy…
| Jennifer Simpson, Sandra Doze, Douglas Urness, David Hailey, Philip Jacobs
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #20. This report presents data from the telepsychiatry program subsequent to the pilot project. The assessment of telepsychiatry beyond the pilot project stage had two primary focuses: a) to develop and document information collection systems initiated during the pilot project evaluation, and b) to assess the operation…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #19. A request for information about the use of low level laser therapy (LLLT) to assist wound healing was received from the Capital Health Authority (CHA). This technology has been increasingly used within the Edmonton area, with somewhat different approaches being taken by individual operators. The concern was…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #16. This report has been prepared in view of the continuing interest in positron emission tomography and other functional diagnostic imaging (FDI) methods within the Alberta health care system. It also continues the work at the Alberta Heritage Foundation for Medical Research in developing approaches to assessment…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #16. This is the second volume of an assessment of functional diagnostic imaging methods in imaging of the myocardium. Volume 1 included an overview of the assessment findings and provided comments on the place of the FDI techniques in this application. In this volume, further details are given of the assessment…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #15. The present health technology assessment report has been prepared following a request by Alberta Health and Wellness for additional information on the use of stereotactic radiosurgery (SRS) in the treatment of acoustic neuroma, one of the applications considered in an earlier publication on SRS. Two main issues…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #14. This report has been prepared because of the interest by the Consumers' Association of Canada and the Health Ministry in the increasing use of newer types of intraocular lenses (IOLs) and in their comparative advantage. The focus of the report is on the safety, efficacy and effectiveness of the three types…